Peter Holleman

Peter Holleman

The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.

Back to news

More news

In search of the optimal treatment strategy for glioblastoma 

In search of the optimal treatment strategy for glioblastoma 

30-05-2023

Patients with recurrent glioblastoma have an unfavorable outlook and few treatment options. The recently launched GLOW study should change this …

Breast cancer awareness month 

Breast cancer awareness month 

30-09-2024

October is the international breast cancer awareness month. Breast cancer is the second most common type of cancer, and the …

Healthcare providers share insights about GENAYA for young adult cancer patients 

Healthcare providers share insights about GENAYA for young adult cancer patients 

17-02-2025

In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl